Pewlett Quayle
Traded as | PQI |
---|---|
Industry | Pharmaceuticals and Biotechnology |
Founded | April 12, 1872 |
Founders | Dr. John Egan Pewlett and Dr. Gerhardt Quayle |
Headquarters | PQ Campus Complex, , |
Area served | Worldwide |
Key people | Dr. Mark Riggs (CEO) |
Products | Pharmaceuticals, Medical equipment, Vaccinations |
Brands | MindEase, Penacilithol, NightEase, SoulEase, Hamhoff's |
Revenue | $40.1 Billion (2021) |
$10.2 Billion (2021) | |
$11.4 Billion (2021) | |
Total assets | $93.4 Billion (2021) |
Total equity | $43.3 Billion (2021) |
Number of employees | 43,700 (2021) |
Divisions | PQ Medical Research, PQ Manufacturing, PQ Technological Research, PQ Worldwide response |
Website | www.pq.com |
Pewlett Quayle is a Delamarian pharmaceutical and health technology company, headquartered in Labrador. PQ is one of the wurld's largest producers of pharmecuticals such as penicillin, paracetomol as well as vaccines. It is also the wurlds largest producer of MRI machines and Ultrasound machines.
The company was founded in 1872 by immigrants Dr. John Egan Pewlett and Dr. Gerhardt Quayle in Labrador. The business initially took the form of a local chemist and a small manufactory. During the Flu of 1881 demand for medication exploded, and Pewlett and Quayle were the only in Labrador with the equipment to keep up with demand. During the outbreak PQ took advantage of the situation and their constant income streams to buy out its rivals in the south east and following the epidemic they were the largest pharmaceutical manufacturer in Delamaria, dominating the industry despite only possesing a few storefronts and two manufactories only a few years prior.